CLINICAL_TRIALS
trial_result
· 2021-07-07
Clinical Trial Update: An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies [Phase 2]
Summary
An extension study of NKTR-102 in cancer patients previously enrolled in NKTR-102 studies (Phase 2) has completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nektar Therapeutics | Conditions: Malignant Solid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2021-07-07